Report error Found 72 Enz. Inhib. hit(s) with all data for entry = 13231
Displayed 1 to 50 (of 72 total ) | Next | Last >>
Affinity DataIC50: 0.170nMAssay Description:Table 1: The experimental methods were operated according to the steps in the kit instruction, and were briefly described as follows: a test compound...More data for this Ligand-Target Pair
Ligand Info
Affinity DataIC50: 0.220nMAssay Description:Table 1: The experimental methods were operated according to the steps in the kit instruction, and were briefly described as follows: a test compound...More data for this Ligand-Target Pair
Ligand Info
Affinity DataIC50: 0.25nMAssay Description:Table 1: The experimental methods were operated according to the steps in the kit instruction, and were briefly described as follows: a test compound...More data for this Ligand-Target Pair
Ligand Info
Affinity DataIC50: 0.290nMAssay Description:Table 1: The experimental methods were operated according to the steps in the kit instruction, and were briefly described as follows: a test compound...More data for this Ligand-Target Pair
Ligand Info
Affinity DataIC50: 0.320nMAssay Description:Table 1: The experimental methods were operated according to the steps in the kit instruction, and were briefly described as follows: a test compound...More data for this Ligand-Target Pair
Ligand Info
Affinity DataIC50: 0.330nMAssay Description:Table 1: The experimental methods were operated according to the steps in the kit instruction, and were briefly described as follows: a test compound...More data for this Ligand-Target Pair
Ligand Info
Affinity DataIC50: 0.340nMAssay Description:Table 1: The experimental methods were operated according to the steps in the kit instruction, and were briefly described as follows: a test compound...More data for this Ligand-Target Pair
Ligand Info
TargetProto-oncogene tyrosine-protein kinase ROS [G2032R](Human)
Zhejiang Hisun Pharmaceutical Co.
US Patent
Zhejiang Hisun Pharmaceutical Co.
US Patent
Affinity DataIC50: 0.340nMAssay Description:Table 6: The experimental flow was briefly described as follows: a test compound was first dissolved in DMSO to prepare a storage solution, and then ...More data for this Ligand-Target Pair
Ligand Info
Affinity DataIC50: 0.360nMAssay Description:Table 1: The experimental methods were operated according to the steps in the kit instruction, and were briefly described as follows: a test compound...More data for this Ligand-Target Pair
Ligand Info
Affinity DataIC50: 0.360nMAssay Description:Table 6: The experimental flow was briefly described as follows: a test compound was first dissolved in DMSO to prepare a storage solution, and then ...More data for this Ligand-Target Pair
Ligand Info
Affinity DataIC50: 0.370nMAssay Description:Table 1: The experimental methods were operated according to the steps in the kit instruction, and were briefly described as follows: a test compound...More data for this Ligand-Target Pair
Ligand Info
Affinity DataIC50: 0.450nMAssay Description:Table 1: The experimental methods were operated according to the steps in the kit instruction, and were briefly described as follows: a test compound...More data for this Ligand-Target Pair
Ligand Info
Affinity DataIC50: 0.470nMAssay Description:Table 1: The experimental methods were operated according to the steps in the kit instruction, and were briefly described as follows: a test compound...More data for this Ligand-Target Pair
Ligand Info
Affinity DataIC50: 0.5nMAssay Description:Table 1: The experimental methods were operated according to the steps in the kit instruction, and were briefly described as follows: a test compound...More data for this Ligand-Target Pair
Ligand Info
Affinity DataIC50: 0.520nMAssay Description:Table 1: The experimental methods were operated according to the steps in the kit instruction, and were briefly described as follows: a test compound...More data for this Ligand-Target Pair
Ligand Info
Affinity DataIC50: 0.560nMAssay Description:Table 1: The experimental methods were operated according to the steps in the kit instruction, and were briefly described as follows: a test compound...More data for this Ligand-Target Pair
Ligand Info
Affinity DataIC50: 0.630nMAssay Description:Table 1: The experimental methods were operated according to the steps in the kit instruction, and were briefly described as follows: a test compound...More data for this Ligand-Target Pair
Ligand Info
Affinity DataIC50: 0.630nMAssay Description:Table 1: The experimental methods were operated according to the steps in the kit instruction, and were briefly described as follows: a test compound...More data for this Ligand-Target Pair
Ligand Info
Affinity DataIC50: 0.700nMAssay Description:Table 1: The experimental methods were operated according to the steps in the kit instruction, and were briefly described as follows: a test compound...More data for this Ligand-Target Pair
Ligand Info
Affinity DataIC50: 0.760nMAssay Description:Table 1: The experimental methods were operated according to the steps in the kit instruction, and were briefly described as follows: a test compound...More data for this Ligand-Target Pair
Ligand Info
Affinity DataIC50: 0.800nMAssay Description:Table 1: The experimental methods were operated according to the steps in the kit instruction, and were briefly described as follows: a test compound...More data for this Ligand-Target Pair
Ligand Info
Affinity DataIC50: 0.820nMAssay Description:Table 1: The experimental methods were operated according to the steps in the kit instruction, and were briefly described as follows: a test compound...More data for this Ligand-Target Pair
Ligand Info
Affinity DataIC50: 0.840nMAssay Description:Table 6: The experimental flow was briefly described as follows: a test compound was first dissolved in DMSO to prepare a storage solution, and then ...More data for this Ligand-Target Pair
Ligand Info
Affinity DataIC50: 0.920nMAssay Description:Table 1: The experimental methods were operated according to the steps in the kit instruction, and were briefly described as follows: a test compound...More data for this Ligand-Target Pair
Ligand Info
Affinity DataIC50: 0.970nMAssay Description:Table 1: The experimental methods were operated according to the steps in the kit instruction, and were briefly described as follows: a test compound...More data for this Ligand-Target Pair
Ligand Info
Affinity DataIC50: 0.980nMAssay Description:Table 1: The experimental methods were operated according to the steps in the kit instruction, and were briefly described as follows: a test compound...More data for this Ligand-Target Pair
Ligand Info
Affinity DataIC50: 1.05nMAssay Description:Table 1: The experimental methods were operated according to the steps in the kit instruction, and were briefly described as follows: a test compound...More data for this Ligand-Target Pair
Ligand Info
Affinity DataIC50: 1.16nMAssay Description:Table 1: The experimental methods were operated according to the steps in the kit instruction, and were briefly described as follows: a test compound...More data for this Ligand-Target Pair
Ligand Info
Affinity DataIC50: 1.17nMAssay Description:Table 1: The experimental methods were operated according to the steps in the kit instruction, and were briefly described as follows: a test compound...More data for this Ligand-Target Pair
Ligand Info
Affinity DataIC50: 1.30nMAssay Description:Table 1: The experimental methods were operated according to the steps in the kit instruction, and were briefly described as follows: a test compound...More data for this Ligand-Target Pair
Ligand Info
Affinity DataIC50: 1.37nMAssay Description:Table 1: The experimental methods were operated according to the steps in the kit instruction, and were briefly described as follows: a test compound...More data for this Ligand-Target Pair
Ligand Info
Affinity DataIC50: 1.66nMAssay Description:Table 1: The experimental methods were operated according to the steps in the kit instruction, and were briefly described as follows: a test compound...More data for this Ligand-Target Pair
Ligand Info
Affinity DataIC50: 1.70nMAssay Description:Table 1: The experimental methods were operated according to the steps in the kit instruction, and were briefly described as follows: a test compound...More data for this Ligand-Target Pair
Ligand Info
Affinity DataIC50: 1.93nMAssay Description:Table 4: The experimental flow was briefly described as follows: a test compound was first dissolved in DMSO to prepare a storage solution, and then ...More data for this Ligand-Target Pair
Ligand Info
Affinity DataIC50: 2.02nMAssay Description:Table 4: The experimental flow was briefly described as follows: a test compound was first dissolved in DMSO to prepare a storage solution, and then ...More data for this Ligand-Target Pair
Ligand Info
TargetHigh affinity nerve growth factor receptor [G595R](Human)
Zhejiang Hisun Pharmaceutical Co.
US Patent
Zhejiang Hisun Pharmaceutical Co.
US Patent
Affinity DataIC50: 2.03nMAssay Description:Table 1: The experimental methods were operated according to the steps in the kit instruction, and were briefly described as follows: a test compound...More data for this Ligand-Target Pair
Ligand Info
Affinity DataIC50: 2.05nMAssay Description:Table 1: The experimental methods were operated according to the steps in the kit instruction, and were briefly described as follows: a test compound...More data for this Ligand-Target Pair
Ligand Info
TargetProto-oncogene tyrosine-protein kinase ROS [G2032R](Human)
Zhejiang Hisun Pharmaceutical Co.
US Patent
Zhejiang Hisun Pharmaceutical Co.
US Patent
Affinity DataIC50: 2.11nMAssay Description:Table 6: The experimental flow was briefly described as follows: a test compound was first dissolved in DMSO to prepare a storage solution, and then ...More data for this Ligand-Target Pair
Ligand Info
Affinity DataIC50: 2.63nMAssay Description:Table 1: The experimental methods were operated according to the steps in the kit instruction, and were briefly described as follows: a test compound...More data for this Ligand-Target Pair
Ligand Info
TargetHigh affinity nerve growth factor receptor [G595R](Human)
Zhejiang Hisun Pharmaceutical Co.
US Patent
Zhejiang Hisun Pharmaceutical Co.
US Patent
Affinity DataIC50: 2.65nMAssay Description:Table 1: The experimental methods were operated according to the steps in the kit instruction, and were briefly described as follows: a test compound...More data for this Ligand-Target Pair
Ligand Info
Affinity DataIC50: 2.80nMAssay Description:Table 1: The experimental methods were operated according to the steps in the kit instruction, and were briefly described as follows: a test compound...More data for this Ligand-Target Pair
Ligand Info
TargetHigh affinity nerve growth factor receptor [G595R](Human)
Zhejiang Hisun Pharmaceutical Co.
US Patent
Zhejiang Hisun Pharmaceutical Co.
US Patent
Affinity DataIC50: 3.31nMAssay Description:Table 1: The experimental methods were operated according to the steps in the kit instruction, and were briefly described as follows: a test compound...More data for this Ligand-Target Pair
Ligand Info
Affinity DataIC50: 3.40nMAssay Description:Table 1: The experimental methods were operated according to the steps in the kit instruction, and were briefly described as follows: a test compound...More data for this Ligand-Target Pair
Ligand Info
TargetHigh affinity nerve growth factor receptor [G595R](Human)
Zhejiang Hisun Pharmaceutical Co.
US Patent
Zhejiang Hisun Pharmaceutical Co.
US Patent
Affinity DataIC50: 3.90nMAssay Description:Table 1: The experimental methods were operated according to the steps in the kit instruction, and were briefly described as follows: a test compound...More data for this Ligand-Target Pair
Ligand Info
TargetHigh affinity nerve growth factor receptor [G667C](Human)
Zhejiang Hisun Pharmaceutical Co.
US Patent
Zhejiang Hisun Pharmaceutical Co.
US Patent
Affinity DataIC50: 4.20nMAssay Description:Table 1: The experimental methods were operated according to the steps in the kit instruction, and were briefly described as follows: a test compound...More data for this Ligand-Target Pair
Ligand Info
TargetHigh affinity nerve growth factor receptor [G595R](Human)
Zhejiang Hisun Pharmaceutical Co.
US Patent
Zhejiang Hisun Pharmaceutical Co.
US Patent
Affinity DataIC50: 4.31nMAssay Description:Table 1: The experimental methods were operated according to the steps in the kit instruction, and were briefly described as follows: a test compound...More data for this Ligand-Target Pair
Ligand Info
Affinity DataIC50: 4.5nMAssay Description:Table 1: The experimental methods were operated according to the steps in the kit instruction, and were briefly described as follows: a test compound...More data for this Ligand-Target Pair
Ligand Info
TargetHigh affinity nerve growth factor receptor [G667C](Human)
Zhejiang Hisun Pharmaceutical Co.
US Patent
Zhejiang Hisun Pharmaceutical Co.
US Patent
Affinity DataIC50: 4.60nMAssay Description:Table 1: The experimental methods were operated according to the steps in the kit instruction, and were briefly described as follows: a test compound...More data for this Ligand-Target Pair
Ligand Info
Affinity DataIC50: 4.83nMAssay Description:Table 1: The experimental methods were operated according to the steps in the kit instruction, and were briefly described as follows: a test compound...More data for this Ligand-Target Pair
Ligand Info
TargetHigh affinity nerve growth factor receptor [G595R](Human)
Zhejiang Hisun Pharmaceutical Co.
US Patent
Zhejiang Hisun Pharmaceutical Co.
US Patent
Affinity DataIC50: 4.97nMAssay Description:Table 1: The experimental methods were operated according to the steps in the kit instruction, and were briefly described as follows: a test compound...More data for this Ligand-Target Pair
Ligand Info